Kezar Life Sciences (KZR) Return on Equity (2021 - 2025)
Historic Return on Equity for Kezar Life Sciences (KZR) over the last 5 years, with Q3 2025 value amounting to 0.58%.
- Kezar Life Sciences' Return on Equity rose 1000.0% to 0.58% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.58%, marking a year-over-year increase of 1000.0%. This contributed to the annual value of 0.55% for FY2024, which is 1000.0% down from last year.
- Per Kezar Life Sciences' latest filing, its Return on Equity stood at 0.58% for Q3 2025, which was up 1000.0% from 0.73% recorded in Q2 2025.
- In the past 5 years, Kezar Life Sciences' Return on Equity ranged from a high of 0.22% in Q3 2022 and a low of 0.73% during Q2 2025
- For the 5-year period, Kezar Life Sciences' Return on Equity averaged around 0.46%, with its median value being 0.45% (2023).
- Its Return on Equity has fluctuated over the past 5 years, first crashed by -2800bps in 2024, then skyrocketed by 1000bps in 2025.
- Over the past 5 years, Kezar Life Sciences' Return on Equity (Quarter) stood at 0.26% in 2021, then grew by 6bps to 0.25% in 2022, then crashed by -105bps to 0.5% in 2023, then crashed by -32bps to 0.67% in 2024, then rose by 13bps to 0.58% in 2025.
- Its Return on Equity was 0.58% in Q3 2025, compared to 0.73% in Q2 2025 and 0.71% in Q1 2025.